Pharmacology, Toxicology and Pharmaceutical Science
Microparticle
53%
Neoplasm
47%
Nanoparticle
45%
Malignant Neoplasm
32%
Porous Silicon
29%
Small Interfering RNA
23%
Methotrexate
22%
Paclitaxel
17%
Chemotherapy
16%
Diseases
15%
Combination Therapy
14%
Controlled Release
14%
Biocompatibility
13%
Nanochannel
13%
Immunotherapy
13%
Cytokine
11%
Melanoma
11%
Metastasis
10%
Doxorubicin
10%
Sustained Release
9%
Lung Metastasis
9%
Breast Cancer
9%
Biodistribution
8%
Biomaterial
8%
Mycobacterium Tuberculosis
8%
Microsphere
8%
Agarose
8%
Hyperthermia
8%
Liposome
8%
Intravital Microscopy
7%
Triple Negative Breast Cancer
7%
Micelle
7%
Inflammation
7%
Macrogol
7%
Silicon Carbide
6%
Growth Factor
6%
Drug Delivery System
6%
Macrogol Derivative
6%
Drug Administration
6%
Polycaprolactone
6%
Mouse Model
6%
Drug Release
5%
Cytotoxicity
5%
Tumor Vascularization
5%
Liver Metastasis
5%
Bovine Serum Albumin
5%
Material Science
Silicon
100%
Nanoparticle
60%
Porous Silicon
47%
Microparticle
37%
Tumor
25%
Surface (Surface Science)
22%
Nanofluidics
18%
Biocompatibility
17%
Macrophage
16%
Stem Cell
13%
Pore Size
13%
Microsphere
13%
Superconducting Material
12%
Contrast Medium
12%
Composite Material
12%
Hydrodynamics
9%
Biomaterial
9%
Bovine Serum Albumin
9%
Film
8%
Silicon Carbide
8%
Nanocrystals
8%
High Temperature Superconductors
8%
Magnetic Resonance Imaging
6%
Platelet
6%
Microfabrication
6%
Proteome
6%
Iron Oxide
5%
Surface Charge
5%
Intravital Microscopy
5%
Keyphrases
Nanochannel
20%
Methotrexate
20%
Delivery Device
10%
Therapeutic Agents
8%
Platelets
8%
Mssbauer Effect
8%
Effect Study
8%
Silicon Microsphere
8%
In Situ Growth
8%
LaFeO3
8%
Mesoporous Silicon
8%
Multistage Vector
6%
Composite Microspheres
6%
Charge Spectra
6%
Controlled Release
6%
Electric Field Gradient
6%
Antiferromagnetic Structure
5%
Mssbauer
5%
Therapeutic Combinations
5%
Therapeutic Toxicity
5%
Time Assessment
5%
Surface Properties
5%
Pore Surface
5%
Quadrupole Interaction
5%
Mössbauer Spectroscopy
5%
Nanocrystalline Materials
5%
Porous Silicon Nanoparticles
5%
Biocompatibility
5%